Skip to content
Search

Latest Stories

Top Stories

Will RFK Jr. Fix America’s Life Expectancy Crisis or Worsen It?

Will RFK Jr. Fix America’s Life Expectancy Crisis or Worsen It?

Education Secretary nominee Linda McMahon (L), and U.S. Health and Human Services Secretary Robert F. Kennedy Jr., (C) appear during a Cabinet meeting at the White House on February 26, 2025 in Washington, DC. U.S.

Getty Images, Andrew Harnik

Robert F. Kennedy, Jr. has never been afraid to challenge conventional wisdom—sometimes aligning with scientific consensus, often rejecting it.

Now, as Secretary of Health and Human Services, Kennedy has the power to shape national healthcare policy. And many will measure his leadership with one critical question: Can he reverse America’s alarming decline in life expectancy?


For decades, the United States has spent more on healthcare than any other nation, yet health outcomes continue to lag behind global peers. According to the Peterson-KFF Health System Tracker, Americans now live four years less than citizens of other high-income countries. The U.S. premature death rate is nearly double that of comparable nations, a gap that has widened in recent years.

Peterson-KFF data points to three primary drivers for this, which together account for 68% of the gap:

  • Chronic disease (32% of the gap)
  • Deaths of despair, including those from substance abuse (12%)
  • The lingering effects of the COVID-19 pandemic (24%)

Of course, Kennedy can’t address every factor contributing to premature death. Many “social determinants of health” (e.g., income, education, and housing), would require sweeping reforms across multiple government agencies, well beyond the scope of HHS.

But when it comes to direct medical interventions, Kennedy can enact meaningful reforms, ones that directly address the leading causes of premature death:


1. Chronic Disease: America’s Worst Health Crisis

According to the Peterson-KFF report, “About a third (32%) of the difference in premature death between the U.S. and similar countries is due to deaths from cardiovascular diseases, chronic respiratory diseases, and chronic kidney diseases.”

Sign up for The Fulcrum newsletter

Compared to citizens of peer nations, Americans are 2.5 times more likely to die from diabetes and nearly four times more likely to die from kidney disease. Preventable cardiovascular disease remains the nation’s leading cause of death.

These problems represent system-wide failures in prevention and management. According to CDC data, if every clinician and health system delivered care at the level of today’s top performers, the nation could prevent 30–50% of the complications tied to chronic conditions, including heart attacks, strokes, cancer, and kidney failure.

Kennedy has led in this area, repeatedly emphasizing the urgency of addressing chronic disease in America. During his Senate confirmation hearing, he stated, “We need to refocus [on chronic disease] if we are going to save our country. This is an existential crisis.”

His Make America Healthy Again (MAHA) initiative promotes shifting the healthcare system’s focus from disease intervention to prevention. This plan encourages community-based programs that improve diet, increase physical activity, and expand preventive screenings.

RFK has also advocated for expanding primary care access, a move that’s well-founded by research. Adding 10 primary care doctors to a community increases life expectancy 2.5 times more than adding 10 specialists, according to a Harvard-Stanford study. To that end, he has talked about shifting healthcare dollars from specialists to primary care physicians.

2. Deaths of Despair: A Growing Crisis

Approximately 12% of the U.S. life expectancy gap can be attributed to “deaths of despair,” which include deaths from drugs, suicides, and alcohol consumption. Combined, they account for 160,000 preventable deaths annually, disproportionately affecting rural and underserved communities, where access to mental health care and addiction treatment is more limited.

While some clinicians see these deaths as primarily societal, the Drug Enforcement Administration (DEA) considers substance use disorder treatment a core medical responsibility and requires all physicians to complete eight hours of training to identify and manage patients with these problems.

Kennedy has long been outspoken about addiction treatment reform, shaped in part by his own personal struggles. He has criticized pharmaceutical companies for fueling the opioid epidemic and vowed to address predatory business practices in addiction treatment.

During his Senate confirmation hearing, Kennedy emphasized the role of technology in expanding healthcare access, particularly in underserved areas. He has advocated for the use of artificial intelligence and telemedicine to bring advanced medical care to rural areas, stating that such innovations could provide “concierge care to every American in this country, even remote parts.”

However, significant advances will require FDA approval of new generative AI tools and Congressional action to allow the provision of telemedicine across states, along with guaranteed Medicare funding for these services.

3. COVID-19: Lessons For Future Pandemics

The COVID-19 pandemic led to over 1 million American deaths and a historic drop in U.S. life expectancy. While every nation suffered, the United States was hit particularly hard. As of 2024, the U.S. has regained only half of the lost years, lagging far behind peer countries.

A major driver of the nation’s high mortality rate was widespread vaccine hesitancy. Though COVID-19 vaccines weren’t a flawless solution, they significantly reduced the risk of hospitalization and death. Still, many Americans—distrustful of public health agencies or swayed by misinformation—chose to forgo them, particularly in more conservative states.

To prevent future infectious disease epidemics, Kennedy will need to reconsider his unscientific views on vaccine risks—whether or not he remains uncertain.

During the Texas measles outbreak, he was slow to endorse vaccination as the best solution, though he eventually acknowledged that “vaccines not only protect individual children from measles but also contribute to community immunity.” While his administration recently removed a fake CDC website, spreading vaccine misinformation, Kennedy also appointed a vaccine safety researcher with a history of promoting discredited theories that linked vaccines to autism.

An Imperfect Leader At The Perfect Time

Kennedy has a rare opportunity to improve American longevity and to position the United States as a global healthcare leader.

By expanding preventive care, strengthening primary care access, and supporting evidence-based mental health and addiction treatments, he could reduce chronic disease and deaths of despair. Science-based interventions would also ensure the nation is better prepared to combat infectious disease threats.

However, if Kennedy undermines public trust in health institutions, promotes unproven treatments, or weakens vaccine programs, preventable deaths will rise and U.S. life expectancy will continue to fall.

The health of millions hinges on the path he chooses.


Dr. Robert Pearl is a Stanford University professor, Forbes contributor, bestselling author, and former CEO of The Permanente Medical Group.

Read More

Anxiety, Fear, and Betrayal: The Emotional Impact of Trump’s 100-Day Blitz

U.S. President Donald Trump talks to reporters on April 23, 2025, in Washington, DC.

(Photo by Chip Somodevilla/Getty Images)

Anxiety, Fear, and Betrayal: The Emotional Impact of Trump’s 100-Day Blitz

Few can deny that whether you love or hate President Donald Trump, the first 100 days of his second term have been marked by bold and controversial actions that will shape American life for years, if not decades, to come. His administration has unleashed a torrent of dramatic moves: a record blitz of executive orders reshaping immigration, trade, and environmental policy; the escalation of trade wars, especially with China, that have rattled global markets; an aggressive effort to slash the size of federal agencies; and policy shifts in international relations, including a realignment on Russia and Ukraine. The stock market’s volatility reflects just how deeply these decisions are impacting the economic climate.

Yet, while the policy fireworks dominate headlines, a less visible but equally profound story is unfolding: the emotional toll Trump's presidency is having on millions of Americans.

Keep ReadingShow less
Just the Facts: Trump's First 100 Days

U.S. President Donald Trump speaks to the media as he departs the White House on April 25, 2025 in Washington, DC.

Getty Images, Kevin Dietsch

Just the Facts: Trump's First 100 Days

The Fulcrum strives to approach news stories with an open mind and skepticism, striving to present our readers with a broad spectrum of viewpoints through diligent research and critical thinking. As best we can, we remove personal bias from our reporting and seek a variety of perspectives in both our news gathering and selection of opinion pieces. However, before our readers can analyze varying viewpoints, they must have the facts.

How has Trump's first 100 days compared to previous presidents, with respect to congressional legislation?

Keep ReadingShow less
How Trump’s First 100 Days Will Radically Alter Health Care

A patient with a medical professional.

Getty Images, Halfpoint Images

How Trump’s First 100 Days Will Radically Alter Health Care

As Donald Trump completes the first 100 days of his second term, the consequences of his early health care decisions are already coming into view. Through executive orders and agency directives, his administration has set a clear national agenda: cut costs, shrink government, and reduce federal oversight.

History shows that decisions made during a president’s first 100 days have an outsized impact on the nation’s future. In 2009, Barack Obama faced a similar window of opportunity. With unified control of the government and pressure to act quickly on health care, he confronted a fundamental choice: expand coverage, improve quality, or cut costs.

Keep ReadingShow less
The Battle To Regulate AI Discrimination

A group of people analyzing ai data.

Getty Images, cofotoisme

The Battle To Regulate AI Discrimination

As states race to regulate AI, they face significant challenges in crafting effective legislation that both protects consumers and allows for continued innovation in this rapidly evolving field.

What is Algorithmic Discrimination?

Often referred to as 'AI bias', it is the underlying prejudice in the data that's used to create AI algorithms which can ultimately result in discrimination - usually due to AI systems reflecting very human biases. These biases can creep in for a number of reasons. The data used to train the AI models may over- or under-represent certain groups. It can also be caused by a developer unfairly weighting factors in algorithmic decision-making based on their own conscious or unconscious biases.

Keep ReadingShow less